首页> 外文期刊>Endocrine journal >Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma
【24h】

Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma

机译:甲状腺髓样癌以外的甲状腺疾病全甲状腺切除术前后血清降钙素水平和钙负荷测试

获取原文
获取原文并翻译 | 示例
       

摘要

Calcitonin is a very sensitive tumor marker of medullary thyroid carcinoma (MTC). Patients with MTC have usually very high levels of serum calcitonin that can be used to diagnose the disease. In order to improve diagnostic sensitivity in family members with small MTCs or to evaluate postoperative biochemical cure status, measurement of calcitonin stimulated with combined intravenous calcium gluconate and pentagastrin has been widely adopted; however, gastrin has become unavailable. Currently, a provocative test using only calcium gluconate is performed; however, the standard values for this test have not been reported. We therefore conducted calcium gluconate stimulation tests in 20 patients before and after total thyroidectomy for thyroid diseases other than MTC. Preoperatively, the mean basal calcitonin level was 24.1 pg/mL and increased to 46.9pg/mL after calcium infusion. The ratio of the peak calcitonin level to the basal value ranged from 1- to 5.23-fold, with a mean of 1.94. The ratio was higher than 3-fold in 3 patients. In 2 patients, peak calcitonin levels exceeded 100 pg/mL. Postoperatively, the mean basal level slightly decreased to 21.15pg/mL and the response to calcium stimulation markedly decreased, with the mean ratio decreasing to 1.1-fold (range, 0.86- to 1.73-fold, maximum peak level, 33 pg/mL). Thus, some subjects without MTC show response to the calcium stimulation test up to 5.24 times the ratio and a peak value of 160 pg/mL, suggesting the requirement for judicious judgment for the early diagnosis of MTC in family members; however, after total thyroidectomy, none of the subjects showed an increase of more than 2-fold or a peak value of 33pg/mL, suggesting that responses greater than 2-fold after MTC surgery might be abnormal, indicating the presence of residual tumor.
机译:降钙素是甲状腺髓样癌(MTC)的非常敏感的肿瘤标志物。 MTC患者通常具有很高的血清降钙素水平,可用于诊断疾病。为了提高MTC较小的家庭成员的诊断敏感性或评估术后生化治愈状态,已广泛采用结合静脉内葡萄糖酸钙和五肽胃泌素刺激的降钙素测定。但是,胃泌素已不可用。目前,仅使用葡萄糖酸钙进行了激发试验。但是,尚未报告该测试的标准值。因此,我们在全甲状腺切除术之前和之后针对20例除MTC以外的甲状腺疾病进行了葡萄糖酸钙刺激试验。术前,基础降钙素的平均水平为24.1 pg / mL,输注钙后增加至46.9 pg / mL。降钙素峰水平与基础值之比为1至5.23倍,平均值为1.94。 3例患者的比率高于3倍。在2例患者中,降钙素峰值水平超过100 pg / mL。术后平均基础水平轻微下降至21.15pg / mL,对钙刺激的反应显着下降,平均比率降低至1.1倍(范围为0.86至1.73倍,最大峰值水平为33 pg / mL) 。因此,一些没有MTC的受试者对钙刺激试验的反应高达该比率的5.24倍,峰值为160 pg / mL,提示需要对家庭成员中的MTC的早期诊断进行明智的判断。然而,在全甲状腺切除术之后,没有一个受试者表现出超过2倍的增加或33pg / mL的峰值,这表明在MTC手术后大于2倍的反应可能是异常的,表明存在残留的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号